Literature DB >> 27413068

Animal Models for Salmonellosis: Applications in Vaccine Research.

Ellen E Higginson1, Raphael Simon1, Sharon M Tennant2.   

Abstract

Salmonellosis remains an important cause of human disease worldwide. While there are several licensed vaccines for Salmonella enterica serovar Typhi, these vaccines are generally ineffective against other Salmonella serovars. Vaccines that target paratyphoid and nontyphoidal Salmonella serovars are very much in need. Preclinical evaluation of candidate vaccines is highly dependent on the availability of appropriate scientific tools, particularly animal models. Many different animal models exist for various Salmonella serovars, from whole-animal models to smaller models, such as those recently established in insects. Here, we discuss various mouse, rat, rabbit, calf, primate, and insect models for Salmonella infection, all of which have their place in research. However, choosing the right model is imperative in selecting the best vaccine candidates for further clinical testing. In this minireview, we summarize the various animal models that are used to assess salmonellosis, highlight some of the advantages and disadvantages of each, and discuss their value in vaccine development.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27413068      PMCID: PMC5014920          DOI: 10.1128/CVI.00258-16

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  137 in total

1.  A bivalent typhoid live vector vaccine expressing both chromosome- and plasmid-encoded Yersinia pestis antigens fully protects against murine lethal pulmonary plague infection.

Authors:  James E Galen; Jin Yuan Wang; Jose A Carrasco; Scott A Lloyd; Gabriela Mellado-Sanchez; Jovita Diaz-McNair; Olga Franco; Amanda D Buskirk; James P Nataro; Marcela F Pasetti
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

2.  Caenorhabditis elegans is a model host for Salmonella typhimurium.

Authors:  A Labrousse; S Chauvet; C Couillault; C L Kurz; J J Ewbank
Journal:  Curr Biol       Date:  2000-11-30       Impact factor: 10.834

3.  Humanized nonobese diabetic-scid IL2rgammanull mice are susceptible to lethal Salmonella Typhi infection.

Authors:  Stephen J Libby; Michael A Brehm; Dale L Greiner; Leonard D Shultz; Michael McClelland; Kelly D Smith; Brad T Cookson; Joyce E Karlinsey; Traci L Kinkel; Steffen Porwollik; Rocio Canals; Lisa A Cummings; Ferric C Fang
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-16       Impact factor: 11.205

Review 4.  Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.

Authors:  Myron M Levine
Journal:  BMC Biol       Date:  2010-10-04       Impact factor: 7.431

5.  The effect of adding iron to mucin on the enhancement of virulence for mice of Salmonella typhi strain TY 2.

Authors:  C J Powell; C R DeSett; J P Lowenthal; S Berman
Journal:  J Biol Stand       Date:  1980

6.  Bovine salmonellosis: experimental production and characterization of the disease in calves, using oral challenge with Salmonella typhimurium.

Authors:  B P Smith; F Habasha; M Reina-Guerra; A J Hardy
Journal:  Am J Vet Res       Date:  1979-11       Impact factor: 1.156

7.  Salmonella typhimurium infection in calves: protection and survival of virulent challenge bacteria after immunization with live or inactivated vaccines.

Authors:  J A Robertsson; A A Lindberg; S Hoiseth; B A Stocker
Journal:  Infect Immun       Date:  1983-08       Impact factor: 3.441

8.  Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression.

Authors:  Gernot Fritsche; Margit Dlaska; Howard Barton; Igor Theurl; Katja Garimorth; Günter Weiss
Journal:  J Immunol       Date:  2003-08-15       Impact factor: 5.422

Review 9.  Animal contact as a source of human non-typhoidal salmonellosis.

Authors:  Karin Hoelzer; Andrea Isabel Moreno Switt; Martin Wiedmann
Journal:  Vet Res       Date:  2011-02-14       Impact factor: 3.683

10.  Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.

Authors:  Orit Gat; James E Galen; Sharon Tennant; Raphael Simon; William C Blackwelder; David J Silverman; Marcela F Pasetti; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2011-11-01
View more
  17 in total

Review 1.  Vaccination against Salmonella Infection: the Mucosal Way.

Authors:  Rémi Gayet; Gilles Bioley; Nicolas Rochereau; Stéphane Paul; Blaise Corthésy
Journal:  Microbiol Mol Biol Rev       Date:  2017-06-14       Impact factor: 11.056

2.  Evaluation of alum-based adjuvant on the immunogenicity of salmonella enterica serovar typhi conjugates vaccines.

Authors:  Erman Tritama; Catur Riani; Indra Rudiansyah; Arip Hidayat; Siti Azizah Kharisnaeni; Debbie Sofie Retnoningrum
Journal:  Hum Vaccin Immunother       Date:  2018-02-21       Impact factor: 3.452

3.  A Combined YopB and LcrV Subunit Vaccine Elicits Protective Immunity against Yersinia Infection in Adult and Infant Mice.

Authors:  Shannon J Heine; Olga L Franco-Mahecha; Khandra T Sears; Cinthia B Drachenberg; Maarten L van Roosmalen; Kees Leenhouts; Wendy L Picking; Marcela F Pasetti
Journal:  J Immunol       Date:  2019-02-20       Impact factor: 5.422

4.  Improved Tolerability of a Salmonella enterica Serovar Typhimurium Live-Attenuated Vaccine Strain Achieved by Balancing Inflammatory Potential with Immunogenicity.

Authors:  Ellen E Higginson; Girish Ramachandran; Aruna Panda; Steven T Shipley; Edwin H Kriel; Louis J DeTolla; Michael Lipsky; Darren J Perkins; Rosangela Salerno-Goncalves; Marcelo B Sztein; Marcela F Pasetti; Myron M Levine; Sharon M Tennant
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

5.  The YrbE phospholipid transporter of Salmonella enterica serovar Typhi regulates the expression of flagellin and influences motility, adhesion and induction of epithelial inflammatory responses.

Authors:  Smriti Verma; Rachel A Prescott; Laura Ingano; Kourtney P Nickerson; Emily Hill; Christina S Faherty; Alessio Fasano; Stefania Senger; Bobby J Cherayil
Journal:  Gut Microbes       Date:  2019-12-12

Review 6.  From Immunologically Archaic to Neoteric Glycovaccines.

Authors:  Marco Cavallari; Gennaro De Libero
Journal:  Vaccines (Basel)       Date:  2017-01-27

7.  Deletions in guaBA and htrA but not clpX or rfaL constitute a live-attenuated vaccine strain of Salmonella Newport to protect against serogroup C2-C3 Salmonella in mice.

Authors:  Fabien J Fuche; Jennifer A Jones; Girish Ramachandran; Ellen E Higginson; Raphael Simon; Sharon M Tennant
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

8.  The use of chicken and insect infection models to assess the virulence of African Salmonella Typhimurium ST313.

Authors:  Lizeth Lacharme-Lora; Siân V Owen; Richard Blundell; Rocío Canals; Nicolas Wenner; Blanca Perez-Sepulveda; Wai Yee Fong; Rachel Gilroy; Paul Wigley; Jay C D Hinton
Journal:  PLoS Negl Trop Dis       Date:  2019-07-26

9.  The Typhoid Toxin Produced by the Nontyphoidal Salmonella enterica Serotype Javiana Is Required for Induction of a DNA Damage Response In Vitro and Systemic Spread In Vivo.

Authors:  Rachel A Miller; Michael I Betteken; Xiaodong Guo; Craig Altier; Gerald E Duhamel; Martin Wiedmann
Journal:  MBio       Date:  2018-03-27       Impact factor: 7.867

10.  Immunogenicity and Induction of Functional Antibodies in Rabbits Immunized with a Trivalent Typhoid-Invasive Nontyphoidal Salmonella Glycoconjugate Formulation.

Authors:  Scott M Baliban; Jessica C Allen; Brittany Curtis; Mohammed N Amin; Andrew Lees; R Nageswara Rao; Gangadhara Naidu; Ramasamy Venkatesan; D Yogeswara Rao; Vadrevu Krishna Mohan; Krishna M Ella; Myron M Levine; Raphael Simon
Journal:  Molecules       Date:  2018-07-17       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.